T2N-32352-84863
3 vaccinations
4 coded responses
17 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 230 / VA
- Registered
- 2022-06-30
- Relationship
- Child or adolescent in my care
- Guardian
- M3A-11574-25074
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-22
Dose 1 — Moderna
-
2022-06-30
Registered in v-safe
- 2022-06-30
- 2022-07-06
-
2022-07-20
Dose 2 — Moderna
- 2022-07-20
- 2022-07-22
- 2022-07-23
- 2022-07-24
- 2022-07-25
- 2022-07-26
- 2022-07-27
-
2022-08-03
Survey response — day 14, dose 2, under 3MedDRA: Exposure to SARS-CoV-2, Irritability, Rhinorrhoea, SARS-CoV-2 test negative — Feeling: FairFree text: 8/1 runny nose started, more fussy- was exposed to a classmate who tested positive 8/1 for COVID, so far (b)(6) has not tested positive on daily rapid testsMedDRA releases: 2024-11 · check-in free text available
- 2022-08-10
- 2022-08-17
-
2022-08-24
Survey response — day 35, dose 2, under 3MedDRA: Nasopharyngitis — Feeling: GoodFree text: Common cold from daycareMedDRA releases: 2024-11 · check-in free text available
-
2022-08-31
Survey response — day 42, dose 2, under 3MedDRA: Nasopharyngitis, SARS-CoV-2 test negative — Feeling: GoodFree text: Viral cold, tested negative for CovidMedDRA releases: 2024-11 · check-in free text available
- 2022-10-19
-
2023-01-18
Survey response — 6 months, dose 2, under 3MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-01-18
Report sent to call center — 6 months, dose 2, under 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2023-01-19
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2023-02-04
Dose 3 — Moderna
- 2023-05-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-22 | Moderna | No |
| 2 | 2022-07-20 | Moderna | No |
| 3 | 2023-02-04 | Moderna | No |
Call center
1 call center case
1 successful
Free text
Release 12 (Under 3) — day 14, dose 2, under 3
Symptoms: 8/1 runny nose started, more fussy- was exposed to a classmate who tested positive 8/1 for COVID, so far (b)(6) has not tested positive on daily rapid tests
redacted (b)(6)
Release 12 (Under 3) — day 35, dose 2, under 3
Symptoms: Common cold from daycare
Release 12 (Under 3) — day 42, dose 2, under 3
Symptoms: Viral cold, tested negative for Covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Irritability | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release